Search Results

You searched for : MultipleSclerosis

	ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel ... Nov 03
	Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
	European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ... Jun 19
	FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients FDA is taking an initiative to authorize the marketing of Portable Neuromodulation Stimulator (PoNS) for Multiple Sclerosis patients which can help patients with their motor ... Apr 15
	USFDA approves Roche’s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
	Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules After Dr Reddy's, Lupin Ltd. also launches Dimethyl Fumarate Delayed-Release Capsules... Oct 06
	Zydus Cadila receives final approval for Dimethyl Fumarate Capsules Dimethyl Fumarate Capsules are indicated for the treatment of multiple sclerosis... Sep 25
	Cipla receives final approval for generic version of Biogen IDEC Inc.’s Tecfidera Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
8 Matching result(s) found!

-Advertisements-

Trending Now
	ACT Fibernet Collaborates with Amazon Prime to Offer Prime Lite Benefits to Consumers June 19, 2025
	CARE Hospitals Conducts “The Power of 3” Public Awareness Drive at Punjagutta JunctionJune 19, 2025
	Legalising key population led health services in Thailand is a gamechangerJune 19, 2025
	MGM Healthcare Successfully Performs Rare Endoscopic Skull Base Surgery on a 1-Year-Old with Brain Herniation inside NoseJune 19, 2025
	Asian Paints’ Apcolite All Protek redefines the Gold Standard in Interior Paints with Breakthrough ‘Lotus Effect Technology’June 19, 2025
	The Soft Touch of Tomorrow: Rural India's Lives Are Being Changed by 3D-Printed LimbsJune 19, 2025
	QNET India Celebrates International Yoga Day with Curated Wellness EssentialsJune 18, 2025
	illumine Raises $2.5M Seed Funding to Globally Scale Vertical AI Platform for Childcare ManagementJune 18, 2025
	Mykare Achieves EBITDA-Positive Status in Elective Surgery Vertical with 80% Revenue GrowthJune 18, 2025
	HCG Manavata Cancer Centre Launches Scalp Cooling Therapy To Prevent Chemotherapy-Induced Hair LossJune 18, 2025
	Biohacking in India: From Blue Light Glasses to Metabolic TrackingJune 18, 2025
	AI-Generated Prescriptions: Will They Ever Be Safe Enough?June 18, 2025
	The Role of Panchayats in Public Health: Untapped Potential in Rural GovernanceJune 18, 2025
	When Medicines Stop Working: How Communities in India Are Fighting BackJune 18, 2025
	Archish Fertility & IVF, India’s First 100% Fully Transparent Fertility Lab, Partners with Amaha Health for Holistic Patient Support & Mental WellbeingJune 17, 2025
	Supporting Mental Health in AutismJune 17, 2025
	New guidelines for monitoring IBD patients to prevent bowel cancerJune 17, 2025
	TTK Prestige Launches Tri-Ply Hexamagic Cookware, Blending Non-Stick Innovation with Triply DurabilityJune 17, 2025
	Turning ₹2.35 Crore of Grant into ₹17.9 Crore of Impact: How Villgro-360 ONE’s Capital For Impact is Benefitting Thousands of Marginalised FarmersJune 17, 2025
	Online Chikitsa Mitra Rolls Out Mobile App for Specialized, In-Home HealthcareJune 17, 2025

Search Results

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients

USFDA approves Roche’s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules

Zydus Cadila receives final approval for Dimethyl Fumarate Capsules

Cipla receives final approval for generic version of Biogen IDEC Inc.’s Tecfidera

Trending Now